Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of November:

• Guggenheim Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 10:00 am (EST)

• Jefferies Global Healthcare Conference (London) on Tuesday, November 18, 2025 at 11:00 am (GMT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251030781106/en/

Incyte Contacts
Media
[email protected]

Investors
[email protected]

Source: Incyte

You May Also Be Interested In

• Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• BREAKING NEWS: ELEKTROS Broadens Its Investor Profile as Lithium, Critical Minerals and Proprietary EV Charging Technology Drive Its Long-Term Growth Story
• BREAKING NEWS: ELEKTROS Broadens Its Investor Profile as Lithium, Critical Minerals and Proprietary EV Charging Technology Drive Its Long-Term Growth Story